DUSP13B and lung carcinoma: To accurately determine the expression level of the SHH/DUSP13B/p‐STAT3 axis in osimertinib‐resistant lung cancer tissues, we collected 10 pairs of clinical lung cancer tissue specimens before and after osimertinib resistance and conducted IHC staining.